Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CYP3A4*22 may increase bleeding risk in ticagrelor users.
Liedes H, Pajula J, Vuorinen AL, De Pretis F, van Gils M, Harno K, Lehto M, Niemi M, Lähteenmäki J. Liedes H, et al. Among authors: lahteenmaki j. Basic Clin Pharmacol Toxicol. 2023 Aug;133(2):202-207. doi: 10.1111/bcpt.13884. Epub 2023 May 31. Basic Clin Pharmacol Toxicol. 2023. PMID: 37162098 Free article. No abstract available.
TWINGEN - protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer's disease.
Vuoksimaa E, Saari TT, Aaltonen A, Aaltonen S, Herukka SK, Iso-Markku P, Kokkola T, Kyttälä A, Kärkkäinen S, Liedes H, Ollikainen M, Palviainen T, Ruotsalainen I, Toivola A, Urjansson M, Vasankari T, Vähä-Ypyä H, Forsberg MM, Hiltunen M, Jalanko A, Kälviäinen R, Kuopio T, Lähteenmäki J, Nyberg P, Männikkö M, Serpi R, Siltanen S; FinnGen; Palotie A, Kaprio J, Runz H, Julkunen V. Vuoksimaa E, et al. Among authors: lahteenmaki j. medRxiv [Preprint]. 2023 Nov 7:2023.11.03.23298018. doi: 10.1101/2023.11.03.23298018. medRxiv. 2023. Update in: BMJ Open. 2024 Jun 12;14(6):e081947. doi: 10.1136/bmjopen-2023-081947 PMID: 37965200 Free PMC article. Updated. Preprint.
TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer's disease.
Vuoksimaa E, Saari TT, Aaltonen A, Aaltonen S, Herukka SK, Iso-Markku P, Kokkola T, Kyttälä A, Kärkkäinen S, Liedes H, Ollikainen M, Palviainen T, Ruotsalainen I, Toivola A, Urjansson M, Vasankari T, Vähä-Ypyä H, Forsberg MM, Hiltunen M, Jalanko A, Kälviäinen R, Kuopio T, Lähteenmäki J, Nyberg P, Männikkö M, Serpi R, Siltanen S, Palotie A, Kaprio J, Runz H, Julkunen V; FinnGen. Vuoksimaa E, et al. Among authors: lahteenmaki j. BMJ Open. 2024 Jun 12;14(6):e081947. doi: 10.1136/bmjopen-2023-081947. BMJ Open. 2024. PMID: 38866570 Free PMC article.
Active assistance technology reduces glycosylated hemoglobin and weight in individuals with type 2 diabetes: results of a theory-based randomized trial.
Orsama AL, Lähteenmäki J, Harno K, Kulju M, Wintergerst E, Schachner H, Stenger P, Leppänen J, Kaijanranta H, Salaspuro V, Fisher WA. Orsama AL, et al. Among authors: lahteenmaki j. Diabetes Technol Ther. 2013 Aug;15(8):662-9. doi: 10.1089/dia.2013.0056. Epub 2013 Jul 11. Diabetes Technol Ther. 2013. PMID: 23844570 Clinical Trial.
26 results